A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced Solid Tumors (Phase 1)
Interventions
DRUG

LNF2007

"LNF2007,9 dose groups:0.2μg/kg、1μg/kg、5μg/kg、20μg/kg、60μg/kg、120μg/kg、240μg/kg、360μg/kg、540μg/kg(0.2\~5μg/kg for accelerated titration, and i3+3 ramp-up starting from 20μg/kg dose group),IV, infusion time 60min±10min, Q4W, until disease progression 、intolerable toxicity or other reasons to stop treatment, the longest administration to 2 years, whichever occurs first."

All Listed Sponsors
lead

Shandong New Time Pharmaceutical Co., LTD

INDUSTRY